Premier Path Wealth Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$837K Buy
9,130
+2,697
+42% +$236K 0.1% 191
2026
Q1
$548K Buy
6,433
+1,965
+44% +$175K 0.07% 254
2025
Q4
$353K Buy
4,468
+1,791
+67% +$140K 0.05% 300
2025
Q3
$214K Sell
2,677
-564
-17% -$48.1K 0.03% 379
2025
Q2
$295K Buy
3,241
+310
+11% +$28.3K 0.04% 327
2025
Q1
$275K Sell
2,931
-309
-10% -$27.7K 0.04% 316
2024
Q4
$295K Buy
3,240
+332
+11% +$31.7K 0.04% 308
2024
Q3
$302K Buy
2,908
+52
+2% +$5.3K 0.05% 300
2024
Q2
$277K Buy
+2,856
New +$263K 0.05% 308

Other funds holding CL

Premier Path Wealth Partners's CL Position: Q2 2026 in Review

Premier Path Wealth Partners increased its Colgate-Palmolive (CL) stake by 42% in Q2 2026, buying an estimated $236K and bringing the position to 9,130 shares worth $837K. The position accounts for 0.1% of the portfolio, ranked #191.

Premier Path Wealth Partners first reported a position in CL in Q2 2024 and has held it in 9 quarters since. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Premier Path Wealth Partners held 9,130 shares of Colgate-Palmolive worth $837K as of Q2 2026.
  • Premier Path Wealth Partners bought 2,697 Colgate-Palmolive shares in Q2 2026, an estimated $236K.
  • Colgate-Palmolive made up 0.1% of Premier Path Wealth Partners's portfolio in Q2 2026, its #191 holding.
  • Premier Path Wealth Partners first reported a position in Colgate-Palmolive in Q2 2024 and has held it in 9 quarters since.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Premier Path Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.